[Cytogenetic analysis of choroidal melanoma]

Arch Soc Esp Oftalmol. 2014 Jan;89(1):17-21. doi: 10.1016/j.oftal.2013.07.012. Epub 2013 Oct 16.
[Article in Spanish]

Abstract

Purpose: To investigate the presence of known cytogenetic alterations of choroidal melanoma in a series of patients diagnosed and treated in our Ocular Oncology Service. A review of the present literature on this topic is also presented.

Methods: Microsatellite analysis (MSA) studies on loss of heterozygosity (LOH) of chromosome 3, as well as multiplex ligation prove amplification (MLPA) on chromosomes 1, 3, 6 and 8, were performed on enucleation or local resection samples obtained from a total of 27 patients, over a 2 year period.

Results: Twenty patients showed at least one of the cytogenetic alterations looked for. A total of 11 cases were found that showed LOH of chromosome 3 (44%), 8 gains of chromosome 8 (30%), 8 gains of chromosome 6p (30%), and 7 partial or total losses of chromosome 1 (26%).

Conclusions: This is the first study on the cytogenetics of choroidal melanoma performed in our country. The results are similar to that published in the literature. Cytogenetic analysis provides more accurate knowledge on a vital individual prognosis. It also may become a valuable tool for establishing the most adequate follow-up regimes, and the need for adjuvant therapies.

Keywords: Análisis de microsatélites; Citogenético; Cytogenetic; Loss of heterozigosity; Melanoma; Micsosatellite analysis; Multiplex-ligation-prove amplification; Pérdida de heterocigosidad; Uveal.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Aneuploidy
  • Brachytherapy
  • Choroid Neoplasms / genetics*
  • Choroid Neoplasms / pathology
  • Choroid Neoplasms / therapy
  • Chromosome Aberrations*
  • Chromosomes, Human / ultrastructure
  • Eye Enucleation
  • Female
  • Humans
  • Loss of Heterozygosity*
  • Male
  • Melanoma / genetics*
  • Melanoma / pathology
  • Melanoma / therapy
  • Microsatellite Repeats*
  • Middle Aged
  • Multiplex Polymerase Chain Reaction
  • Prognosis
  • Tumor Burden